Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 430-610-6 | CAS number: 226996-19-6
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In the bacterial mutation test (Ames test), up to 5000 µg/plate no signs of toxicity and no mutagenic activity were observed.
In the chromosomal aberration test with human lymphocytes, no increases in the proportion of metaphase figures containing aberrations occurred.
In the third in vitro test, the mouse lymphoma assay, TN-105 did not reveal a mutagenic potential.
In summary, the in vitro battery of mutagenicity showed a statistically clear negative outcome.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
